RB
Richmond Brothers Portfolio holdings
AUM
$153M
This Quarter Return
-2.41%
1 Year Return
+15.91%
3 Year Return
+117.95%
5 Year Return
–
10 Year Return
–
AUM
$53.2M
AUM Growth
+$53.2M
(-14%)
Cap. Flow
-$5.51M
Cap. Flow
% of AUM
-10.35%
Top 10 Holdings %
Top 10 Hldgs %
92.72%
Holding
25
New
3
Increased
6
Reduced
14
Closed
1
Top Buys
| 1 |
Applied Therapeutics
APLT
|
$308K |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$267K |
| 3 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$87.6K |
| 4 |
Heron Therapeutics
HRTX
|
$62.4K |
| 5 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$60.9K |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$1.62M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$974K |
| 3 |
MiMedx Group
MDXG
|
$767K |
| 4 |
Apple
AAPL
|
$684K |
| 5 |
Microsoft
MSFT
|
$607K |
Sector Composition
| 1 | Healthcare | 26.15% |
| 2 | Technology | 14.18% |
| 3 | Financials | 10.16% |
| 4 | Consumer Discretionary | 1.56% |
| 5 | Communication Services | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco QQQ Trust
QQQ
$364B
| $16.7M | 31.4% |
46,638
-4,525
| -9% | -$1.62M |
|
|
2
MiMedx Group
MDXG
$1.05B
| $10.8M | 20.28% |
1,481,332
-105,168
| -7% | -$767K |
|
|
3
Apple
AAPL
$3.45T
| $5.89M | 11.06% |
34,395
-3,994
| -10% | -$684K |
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $5.41M | 10.16% |
15,440
-2,781
| -15% | -$974K |
|
5
Guggenheim Strategic Opportunities Fund
GOF
$2.62B
| $3.86M | 7.24% |
260,700
+2,040
| +0.8% | +$30.2K |
|
|
6
Microsoft
MSFT
$3.77T
| $1.66M | 3.11% |
5,247
-1,920
| -27% | -$607K |
|
7
ARK Innovation ETF
ARKK
$7.45B
| $1.53M | 2.87% |
38,540
-11,592
| -23% | -$460K |
|
8
iShares Biotechnology ETF
IBB
$5.6B
| $1.42M | 2.67% |
11,616
-1,794
| -13% | -$219K |
|
|
IRD
9
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $1.23M | 2.32% |
368,003
+26,143
| +8% | +$87.6K |
|
10
Rockwell Medical
RMTI
$58.9M
| $854K | 1.6% |
410,352
-12,272
| -3% | -$25.5K |
|
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.53B
| $591K | 1.11% |
57,336
-5,115
| -8% | -$52.7K |
|
12
Amazon
AMZN
$2.44T
| $490K | 0.92% |
3,855
+97
| +3% | +$12.3K |
|
13
iShares Core S&P 500 ETF
IVV
$662B
| $395K | 0.74% |
919
+14
| +2% | +$6.01K |
|
14
McDonald's
MCD
$224B
| $339K | 0.64% |
1,287
-254
| -16% | -$67K |
|
15
Air Industries Group
AIRI
$15.2M
| $320K | 0.6% |
111,319
-16,571
| -13% | -$47.6K |
|
|
16
Applied Therapeutics
APLT
$71M
| $308K | 0.58% |
+123,654
| New | +$308K |
|
|
AXNX
17
DELISTED
Axonics, Inc. Common Stock
AXNX
| $267K | 0.5% |
+4,749
| New | +$267K |
|
18
Alphabet (Google) Class C
GOOG
$2.58T
| $261K | 0.49% |
1,980
-1,820
| -48% | -$240K |
|
19
Procter & Gamble
PG
$368B
| $226K | 0.42% |
1,549
-53
| -3% | -$7.73K |
|
20
Johnson & Johnson
JNJ
$427B
| $210K | 0.4% |
1,349
| – | – |
|
21
Verizon
VZ
$186B
| $206K | 0.39% |
6,342
-811
| -11% | -$26.3K |
|
|
ONCT
22
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $148K | 0.28% |
494,042
+203,010
| +70% | +$60.9K |
|
|
23
Heron Therapeutics
HRTX
$207M
| $106K | 0.2% |
103,009
+60,604
| +143% | +$62.4K |
|
|
CRGE
24
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $9.94K | 0.02% |
+20,000
| New | +$9.94K |
|
25
Invesco Global Listed Private Equity ETF
PSP
$332M
| – | – |
-52,889
| Closed | -$556K |
|